MSH|^~\&|ADM|ARH|||202001141310||ADT^A08|4146080|D|2.2|||AL|NE
EVN|A08|202001141310||||
PID|1|FHATVIG0012080|AB00008298|AB8205|PCSTEST^REPORT1||19631021|F|||123 Arbutus Way^^Victoria^BC^V6H 9I0|||||||AB000580/19|
PV1|1|I|AB-2BAKER^AB2B-FLO^E|UE|||ZTEST^Test Provider^IM/IT^Use Only^^^^^^^^^XX|||MEDS||||||||IN|||||||||||||||||||||ARH|||||201910211147|
PV2||W^Ward|
OBX|1|ST|1010.1^WEIGHT^CPT4||75.000||||||F
OBX|2|ST|1010.3^HEIGHT^CPT4||170.0||||||F
OBX|3|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20190723||||||F
OBX|4|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCC^BC CareCard (No Photo ID)||||||F
OBX|5|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|6|CE|ADM MDRO4^Bangladesh or Vietnam in the last 12 months?^ADM||N^NO||||||F
OBX|7|CE|ADM MRSA2^correctional/shelter in the last 12 months?^ADM||N^NO||||||F
OBX|8|TX|Ac00000000^Specialty skin product used^ADM||N||||||F
OBX|9|TX|Ac00000100^Hair washed^ADM||Y||||||F
OBX|10|CE|Ac00000700^Upper body washing support provided^ADM||2^Supervision||||||F
OBX|11|TX|Ac00000800^Bathing support comment^ADM||bathing comments||||||F
OBX|12|CE|Ac00000900^Mouth care support provided^ADM||8^Independent||||||F
OBX|13|CE|Ac00001000^Grooming support provided^ADM||2^Supervision||||||F
OBX|14|CE|Ac00001100^Toileting hygiene ability^ADM||2^Supervision||||||F
OBX|15|CE|Ac00001200^Oral care support provided^ADM||5^Total||||||F
OBX|16|CE|Ac00001300^Dressing support provided^ADM||7^2 person assist||||||F
OBX|17|CE|Ac00001400^Bed mobility support provided^ADM||8^Independent||||||F
OBX|18|CE|Ac00003700^Lower body washing support provided^ADM||2^Supervision||||||F
OBX|19|CE|Ac00005400^Aids in use^ADM||2^Dentures||||||F
OBX|20|TX|Ac00005500^Aids in use other^ADM||aids in use other||||||F
OBX|21|CE|Ac00005600^Aids removed^ADM||1^Glasses||||||F
OBX|22|TX|Ac00005700^Aids removed other^ADM||aids removed other||||||F
OBX|23|TX|Ac00005800^Assistance given^ADM||N||||||F
OBX|24|TX|Ac00005900^Aids comments^ADM||aids comments||||||F
OBX|25|CE|Ac00006000^Bathing support provided^ADM||7^2 person assist||||||F
OBX|26|TX|Ac00006100^Specialty skin product used^ADM||N||||||F
OBX|27|TX|AcADLCOM00^Activities of Daily Living Comments^ADM||other adl comments||||||F
OBX|28|CE|AcADLWAT00^Wash type performed^ADM||1^Full bed bath||||||F
OBX|29|CE|AcADLWAT01^Wash type performed^ADM||1^Full bed bath||||||F
OBX|30|CE|AcCLTYPE00^Clothing type^ADM||2^Hospital pajamas||||||F
OBX|31|CE|AcEYECAR00^Eye care^ADM||2^Saline||||||F
OBX|32|CE|AcFTTYPE00^Footwear type^ADM||1^Non slip socks||||||F
OBX|33|CE|AcHAIWAS00^Hair wash performed^ADM||1^With hair cap||||||F
OBX|34|TX|AcHMRF0001^Falls since admission^ADM||N||||||F
OBX|35|TX|AcHYGIEN00^Hygiene/Dependent patient comments^ADM||other hygiene comments||||||F
OBX|36|CE|AcMOCAPE01^Mouth care performed^ADM||2^Antibacterial oral rinse~8^Dentures cleansed||||||F
OBX|37|TX|AcMOUCAO00^Mouth care performed other^ADM||other oral care||||||F
OBX|38|CE|AcPER00001^Personal care provided by^ADM||1^Nurse||||||F
OBX|39|TX|AcPER00100^Personal care provided by other^ADM||ggrandmother||||||F
OBX|40|TX|AcPERSCC00^Personal care comments^ADM||personal care comments '~line 2~line 3||||||F
OBX|41|CE|AcPRUSED00^Physical restraint used^ADM||1^Soft Velcro||||||F
OBX|42|TX|AcPRUSEO00^Physical restraint used other^ADM||restraint other||||||F
OBX|43|TX|AcSHAGIV00^Shave given^ADM||Y||||||F
OBX|44|TX|AcSUPADL00^Recommended support provided for ADL comments^ADM||Recommended support provided for ADL comments~line 2~line 3||||||F
OBX|45|CE|AcSUPPGR00^Recommended support provided for grooming^ADM||3^Set-up||||||F
OBX|46|CE|AcSUPPLE01^Recommended support provided for LE dressing^ADM||2^Supervision||||||F
OBX|47|CE|AcSUPPUE00^Recommended support provided for UE dressing^ADM||3^Set-up||||||F
OBX|48|CE|AcSUPPWS00^Recommended support provided for washing^ADM||2^Supervision||||||F
OBX|49|TX|AdADMDAT01^Admission date^ADM||20200114||||||F
OBX|50|CE|AdADMFRO01^Admitted from^ADM||1^Emergency||||||F
OBX|51|TX|AdADMRSN00^Reason for admission^ADM||COPD exacerbation, r/o pneumonia||||||F
OBX|52|TX|AdADMTIM00^Admission time^ADM||0100||||||F
OBX|53|TX|AdALLERR00^Allergies reviewed^ADM||Y||||||F
OBX|54|CE|AdASEVRD00^As evidenced by^ADM||19^Decreased fat mass||||||F
OBX|55|TX|AdDCBNUR00^Discharge barriers identified by nursing^ADM||Updating discharge barriers nursing query||||||F
OBX|56|CE|AdDISCHA30^Discharge destination^ADM||3^Assisted living||||||F
OBX|57|TX|AdEDADLO00^Other care activity comments^ADM||other care comments form care summary rehab~line 2 other care~line 3 other care||||||F
OBX|58|TX|AdESTDTD00^Estimated date of discharge^ADM||20191217||||||F
OBX|59|CE|AdESTREA03^Reason EDD changed^ADM||6^Family/Social issues||||||F
OBX|60|TX|AdFACINA01^Name of facility^ADM||some cool place||||||F
OBX|61|TX|AdGOCPRD00^Goal^ADM||opp||||||F
OBX|62|CE|AdGOSTRD00^Goal status^ADM||3^Met||||||F
OBX|63|TX|AdGOTDRD00^Goal target date^ADM||20191122||||||F
OBX|64|TX|AdHXCOND00^History of presenting condition^ADM||increasing SOB and 3 day history of fever/chills.  on Abx.  Poor intakes,~dark urine||||||F
OBX|65|CE|AdINPTRF00^Inpatient referral(s) sent to^ADM||1^Audiologist||||||F
OBX|66|CE|AdINVARD00^Interventions to address problem^ADM||2^Enteral nutrition||||||F
OBX|67|CE|AdNICOT000^History of nicotine use^ADM||2^Current use||||||F
OBX|68|CE|AdNICOT010^Type of nicotine use^ADM||1^Cigarettes||||||F
OBX|69|TX|AdNICOT030^Number of cigarettes smoked per day^ADM||20||||||F
OBX|70|TX|AdNICOT040^Number of years smoking^ADM||20||||||F
OBX|71|TX|AdNICOT050^Cigarette pack years amount^ADM||20.00||||||F
OBX|72|TX|AdOTCPDB00^Discharge barriers identified by occupational therapist^ADM||discharge barriers identified by occupational therapist from CDP - OT~ischarge barriers identified by occupational therapist from CDP - OT~ischarge barriers identified by occupational therapist from CDP - OT||||||F
OBX|73|TX|AdOTCPDE01^Problem detail^ADM||unable||||||F
OBX|74|CE|AdOTCPID01^Problem identified^ADM||1^Ability to complete ADLs||||||F
OBX|75|CE|AdOUTM0000^Outpatient/Community referral(s) sent to^ADM||1^Acquired brain injury||||||F
OBX|76|TX|AdPROBDC00^Problem is a barrier to discharge^ADM||Y||||||F
OBX|77|CE|AdPROBRD00^Problem identified^ADM||35^Inadequate protein-E||||||F
OBX|78|CE|AdRETORD00^Related to^ADM||1^Altered GI function||||||F
OBX|79|TX|AdSTRECO01^Reason EDD changed other^ADM||HJ testing for Donna||||||F
OBX|80|CE|CaACSQWA00^Arterial catheter square wave assessment^ADM||1^Optimally dampened||||||F
OBX|81|CE|CaARTM0001^Arterial catheter insertion site^ADM||1^Right radial||||||F
OBX|82|TX|CaCAMODA00^Date cardiac monitoring initiated^ADM||20191007||||||F
OBX|83|TX|CaCAMODD00^Date cardiac monitoring discontinued^ADM||20191114||||||F
OBX|84|TX|CmMRPCDA01^MRP or physician communication date^ADM||20200114||||||F
OBX|85|CE|CmMRPCDE01^MRP or physician contact details^ADM||1^Contact made||||||F
OBX|86|CE|CmMRPCME01^MRP or physician communication method^ADM||2^By phone||||||F
OBX|87|TX|CmMRPCOC01^MRP or physician communication outcome^ADM||transfer patient to ICU||||||F
OBX|88|TX|CmMRPCRE01^MRP or physician communication reason^ADM||informed of respiratory acidosis||||||F
OBX|89|TX|CmMRPCTI01^MRP or physician communication time^ADM||1240||||||F
OBX|90|TX|EnPA000100^Palliative Performance Scale^ADM||75||||||F
OBX|91|CE|GiBM000000^Bowel movement method^ADM||1^Toilet||||||F
OBX|92|TX|GiBMINCO00^Bowel movement incontinence^ADM||Y||||||F
OBX|93|TX|GiBO000301^Last bowel movement date as reported by patient^ADM||20191113||||||F
OBX|94|CE|GiETDEDE00^Enteral feeding tube delivery service^ADM||2^Pump||||||F
OBX|95|TX|GuBDINCO00^Bladder incontinence^ADM||Y||||||F
OBX|96|CE|GuBDVM0002^Voiding method^ADM||1^Toilet~2^Urinal||||||F
OBX|97|TX|GuBDVMO000^Voiding method other^ADM||voiding method other||||||F
OBX|98|TX|GuUCID0000^Urinary catheter insertion date^ADM||20191211||||||F
OBX|99|TX|GuUCRDT000^Urinary catheter removal date^ADM||20191213||||||F
OBX|100|TX|He00002400^Oral care comments^ADM||comments||||||F
OBX|101|TX|HxIIGAWD00^Gestational age^ADM||77 weeks 2 days||||||F
OBX|102|TX|HxIIGEDA00^Gestational age in days^ADM||2||||||F
OBX|103|TX|HxIIGEWE00^Gestational age in weeks^ADM||77||||||F
OBX|104|TX|HxOXADM002^History of home oxygen use^ADM||Y||||||F
OBX|105|TX|HxPICUV001^Previous ICU admissions and/or ventilation^ADM||N||||||F
OBX|106|TX|HxSPTCHX01^Pertinent clinical history^ADM||T2DM, COPD, MI in 2014, obesity||||||F
OBX|107|CE|HxWHX00002^Weight change prior to admission weight history^ADM||1^Stable||||||F
OBX|108|TX|InARINAT01^Attempt number^ADM||1||||||F
OBX|109|TX|InEYECAR00^Eye care^ADM||N||||||F
OBX|110|TX|InWDRDRY00^Wound dressing dry and intact^ADM||Y||||||F
OBX|111|CE|InWNDLOC02^Wound location^ADM||2^Arm||||||F
OBX|112|CE|InWNDMOD00^Wound location modifier^ADM||1^Right||||||F
OBX|113|CE|InWNDTYM00^Wound type^ADM||2^Arterial||||||F
OBX|114|CE|IvARTINS01^Arterial line insertion reason^ADM||1^Continuous BP monitoring||||||F
OBX|115|CE|MhREST0001^Reason for restraint use^ADM||2^Harm to others||||||F
OBX|116|TX|MhREST0002^Reason for restraint use other^ADM||reason for use||||||F
OBX|117|TX|MhRESTEV01^Evaluation for continued restraint use assessed/reassessed^ADM||N||||||F
OBX|118|CE|Mo00000100^Repositioning support provided^ADM||2^Supervision||||||F
OBX|119|CE|Mo00000300^Transfer support provided for chair to bed transfer^ADM||6^1 person assist||||||F
OBX|120|CE|Mo00000400^Transfer support provided for toilet transfer^ADM||6^1 person assist||||||F
OBX|121|CE|Mo00000500^Ambulation support provided^ADM||6^1 person assist||||||F
OBX|122|CE|Mo00000600^Upper body dressing support provided^ADM||2^Supervision||||||F
OBX|123|TX|Mo00000700^Dressing comments^ADM||dressing comments||||||F
OBX|124|CE|Mo00000800^Lower body dressing support provided^ADM||3^Set-up||||||F
OBX|125|CE|Mo00001200^Dressing support provided (footwear)^ADM||3^Set-up||||||F
OBX|126|CE|Mo00001300^Wheelchair propulsion^ADM||2^Supervision||||||F
OBX|127|TX|Mo00002600^Bed mobility comment^ADM||bed mobility comments||||||F
OBX|128|CE|MoAIDAMB01^Ambulation aid^ADM||11^Walker: 4 wheeled||||||F
OBX|129|CE|MoAIDTRA01^Transfer aid^ADM||11^Walker: 4 wheeled||||||F
OBX|130|CE|MoAMBLOC00^Ambulation location^ADM||1^Within room||||||F
OBX|131|TX|MoBDACMT00^Mobility in bed assistance required comment^ADM||bed mobility comments||||||F
OBX|132|CE|MoBDASTD00^Mobility in bed assistive devices^ADM||1^Bed rail||||||F
OBX|133|CE|MoBDIN0000^In bed mobilization^ADM||1^Positioned in bed||||||F
OBX|134|CE|MoEQUITR01^Transfer equipment^ADM||17^Mechanical lift||||||F
OBX|135|TX|MoEXCPRE00^Exercises prescribed^ADM||Exercises prescribed||||||F
OBX|136|CE|MoEXERB00^Exercises in bed^ADM||1^UE ROM~2^LE ROM||||||F
OBX|137|TX|MoEXERBC00^Bed exercises completed^ADM||Y||||||F
OBX|138|CE|MoFA000001^Fall prevention strategies^ADM||1^Universal~15^Non-slip socks||||||F
OBX|139|CE|MoMOTYPE00^Mobility type^ADM||5^Bathtub transfer||||||F
OBX|140|CE|MoMOTYPT00^Mobility type^ADM||4^Toilet transfer||||||F
OBX|141|TX|MoPHYSIO00^Physiotherapy treatment^ADM||PT treatment||||||F
OBX|142|CE|MoPOBDPO01^Bed position^ADM||4^Low fowlers (30-45 deg)||||||F
OBX|143|CE|MoPOSRBM00^Positioning side rails bottom^ADM||2^Both up||||||F
OBX|144|CE|MoPOSRTP00^Positioning side rails top^ADM||1^1 side up||||||F
OBX|145|TX|MoPTPLAN00^PT plan^ADM||PT Plan from UAP PT~PT Plan from UAP PT~PT Plan from UAP PT||||||F
OBX|146|CE|MoRECAID02^Recommended aid^ADM||11^Walker: 4 wheeled||||||F
OBX|147|CE|MoRECEQP02^Recommended equipment^ADM||31^Tub clamp bar||||||F
OBX|148|CE|MoRECTEC00^Recommended mobility technique^ADM||2^To left side||||||F
OBX|149|CE|MoSUPPPT01^Recommended support provided^ADM||2^Supervision||||||F
OBX|150|CE|MoSUPPPV03^Recommended support provided^ADM||7^2 person assist||||||F
OBX|151|TX|MoTHERPY00^Therapy recommendations comments^ADM||Therapy recommendations comments form Bathtub transfer from UAP PT~line 2 UAP PT~line 3 UAP PT||||||F
OBX|152|TX|MoTRANCO00^Transfer comments^ADM||Mobility/Transfer comments~line 2~line 3 from care summary Rehab||||||F
OBX|153|CE|MoTRANSF00^Transfer from^ADM||3^Commode||||||F
OBX|154|CE|MoTRANST02^Transfer to^ADM||1^Bed||||||F
OBX|155|CE|MoTRSEMR00^Transfer support provided^ADM||2^Supervision||||||F
OBX|156|CE|MoTRSUP002^Transfer support provided^ADM||2^Supervision||||||F
OBX|157|CE|Ms00000800^Type^ADM||3^Serial||||||F
OBX|158|CE|Ms00001400^Type^ADM||2^Brace||||||F
OBX|159|TX|Ms00001500^Type details^ADM||aspen||||||F
OBX|160|TX|Ms00001600^Location Modifier^ADM||neck||||||F
OBX|161|TX|Ms00001700^Location^ADM||neck||||||F
OBX|162|CE|Ms00001800^Splint/Brace status^ADM||1^On||||||F
OBX|163|TX|Ms00001900^Splint/Brace comments^ADM||checked position||||||F
OBX|164|TX|Ms00002000^Skin satisfactory^ADM||Y||||||F
OBX|165|CE|MsORTH0003^Supportive orthosis for mobilization^ADM||1^Aspen collar~5^Vista collar||||||F
OBX|166|TX|MsPTSMRT00^PT SMART goals^ADM||PT SMART goals form UAP PT~line 2 UAP PT~line 3 UAP PT||||||F
OBX|167|CE|NeLECONS00^Level of consciousness^ADM||2^Drowsy||||||F
OBX|168|CE|NeORIENT00^Oriented^ADM||1^To person~2^To place~3^To time~4^To situation||||||F
OBX|169|TX|NmEX010000^Home exercise program^ADM||home exercise program||||||F
OBX|170|TX|NuAPWECH01^Percent weight loss^ADM||1.3||||||F
OBX|171|CE|NuAPWELO01^Dietitian weight loss assessment^ADM||1^Non-significant loss||||||F
OBX|172|TX|NuCALTAR00^Target calories per day^ADM||1800 kcal/kg||||||F
OBX|173|TX|NuCLIJUD00^Clinical judgement factors other^ADM||other clinical judegement||||||F
OBX|174|TX|NuCNCCFD00^Coordination of nutrition care collaboration focus details^ADM||collaboration details from coordination of care intervention||||||F
OBX|175|CE|NuCNCCFO00^Coordination of nutrition care collaboration focus^ADM||6^Swallowing||||||F
OBX|176|CE|NuCNCICT00^Coordination of nutrition care interprofessional care type^ADM||3^Referral||||||F
OBX|177|CE|NuCNCPCW01^Interprofessional providers collaborated with^ADM||5^SLP||||||F
OBX|178|CE|NuCNFEED00^Current nutrition status refeeding concern^ADM||1^No risk||||||F
OBX|179|CE|NuCNFEED01^Current nutrition status refeeding concern^ADM||2^Possible risk||||||F
OBX|180|CE|NuCNJUCO00^Current nutrition status based on clinical judgement^ADM||1^Usual intake||||||F
OBX|181|CE|NuCNJUDG00^Nutrition status based on clinical judgement^ADM||3^Severely malnourished||||||F
OBX|182|CE|NuCNMETH00^Nutrition status assessment method^ADM||3^Clinical judgement||||||F
OBX|183|TX|NuDIETFU00^Dietitian follow-up required^ADM||Y||||||F
OBX|184|CE|NuDIFOTF02^Dietitian follow-up time frame^ADM||2^In 2-3 days||||||F
OBX|185|CE|NuDIFUIM02^Dietitian follow up items to monitor^ADM||2^GI symptoms~5^Bowel function~13^Supplement acceptance~16^Labs~19^Blood glucose||||||F
OBX|186|TX|NuDPMEHX00^Clinical history relevant to dietitian plan^ADM||L MCA stroke HTN, Diabetes||||||F
OBX|187|TX|NuDPTEST01^Lab/Test/Procedure results relevant to dietitian plan^ADM||hyponatremia||||||F
OBX|188|CE|NuDRREAS05^Reason for dietitian assessment^ADM||4^Enteral nutrition||||||F
OBX|189|CE|NuEDUCON00^Nutrition education content^ADM||2^Priority modifications||||||F
OBX|190|CE|NuENCACO00^EN calculation considerations^ADM||1^Account for interruptions||||||F
OBX|191|CE|NuENCAFA02^EN calculation factor^ADM||3^Based on 24 hours/day||||||F
OBX|192|TX|NuENCALP00^Calories provided by enteral nutrition^ADM||1930||||||F
OBX|193|TX|NuENDEHR00^Enteral nutrition delivery hours per day^ADM||23||||||F
OBX|194|CE|NuENENAS00^Estimated energy assessment method^ADM||1^kcal/kg||||||F
OBX|195|TX|NuENENCK00^Energy estimated needs (kcal/kg)^ADM||1875.000||||||F
OBX|196|TX|NuENFETU00^Enteral feeding tube description^ADM||12 french||||||F
OBX|197|CE|NuENFLME01^Fluid assessment method^ADM||1^1 mL/kcal||||||F
OBX|198|CE|NuENFLTR00^Feeding tube flush type recommendation^ADM||1^Water||||||F
OBX|199|TX|NuENFLUN00^Fluid estimated needs^ADM||1900||||||F
OBX|200|TX|NuENGTFR00^Goal tube feed rate^ADM||70||||||F
OBX|201|CE|NuENIDSC00^EN initial delivery schedule^ADM||1^Continuous||||||F
OBX|202|TX|NuENITFR00^Initial tube feed rate^ADM||25||||||F
OBX|203|CE|NuENKCKG00^Energy kcal/kg/day factor^ADM||2^25 kcal/kg||||||F
OBX|204|CE|NuENNUST02^Enteral nutrition strategy^ADM||4^Initiate EN||||||F
OBX|205|TX|NuENPNNU00^Enteral/Parenteral details^ADM||Isosouce 1.2 at 70 mL/hour||||||F
OBX|206|CE|NuENPNST00^Enteral/Parenteral nutrition stage^ADM||3^Goal||||||F
OBX|207|TX|NuENPPRO00^Protein provided by enteral nutrition^ADM||87||||||F
OBX|208|CE|NuENPRSC00^EN progression schedule as tolerated^ADM||3^q4h||||||F
OBX|209|TX|NuENRAPR00^EN rate progression as tolerated^ADM||25||||||F
OBX|210|TX|NuENSOLU02^Enteral nutrition formula or solution^ADM||Isosource||||||F
OBX|211|CE|NuENTYPE01^Formula or solution type^ADM||2^1.2 kcal/mL||||||F
OBX|212|CE|NuFACFTR00^Current feeding tube route^ADM||1^Nasal||||||F
OBX|213|TX|NuFADIHX00^Diet history relevant to dietitian plan^ADM||eating well prior to admission||||||F
OBX|214|CE|NuFAFTTY00^Current feeding tube type^ADM||1^Small bore feeding tube||||||F
OBX|215|CE|NuFKLEVE00^Food and nutrition knowledge level^ADM||2^Basic||||||F
OBX|216|CE|NuFOSOSY00^Formula or solution system type^ADM||2^Closed||||||F
OBX|217|TX|NuFRWAEN01^Total free water provided excluding flushes^ADM||1300||||||F
OBX|218|CE|NuKNOW0001^Knowledge assessment of^ADM||1^Patient~3^Family||||||F
OBX|219|CE|NuNIADEQ00^Nutrient intake adequacy^ADM||1^Adequate||||||F
OBX|220|TX|NuNICUF391^Current feeding plan^ADM||EBM 46 ml||||||F
OBX|221|CE|NuNIFLSO00^Nutrient intake fluid sources considered^ADM||3^Enteral formula||||||F
OBX|222|TX|NuNIFLUI00^Nutrient intake fluid^ADM||1300||||||F
OBX|223|TX|NuNINIEN00^Energy estimated intake^ADM||1900||||||F
OBX|224|CE|NuNINSCO00^Nutrient sources considered^ADM||3^Enteral nutrition||||||F
OBX|225|TX|NuNIPTEI00^Protein estimated intake^ADM||85||||||F
OBX|226|CE|NuNUTUBW01^Nutrition status based on usual body weight^ADM||2^Mildly malnourished||||||F
OBX|227|CE|NuONBARR01^Barriers to eating^ADM||22^NPO||||||F
OBX|228|TX|NuONINTA00^Oral nutrition current food intake^ADM||NPO x 2 days||||||F
OBX|229|TX|NuONORDI01^Oral diet type^ADM||NPO||||||F
OBX|230|TX|NuPEDFEE00^Diet type^ADM||diet type||||||F
OBX|231|TX|NuPRESTN00^Protein estimated needs number 2^ADM||82.50||||||F
OBX|232|TX|NuPRFWTK00^Protein factor for weight number 2^ADM||1.1||||||F
OBX|233|CE|NuREFERO00^Recommended feeding route^ADM||1^Gastric||||||F
OBX|234|TX|NuSGA00100^SGA weight change - overall loss in past 6 months^ADM||1.000||||||F
OBX|235|CE|NuSGA00300^SGA weight change in past 2 weeks^ADM||3^Decrease||||||F
OBX|236|TX|NuSGA00501^SGA intake change duration^ADM||3 months||||||F
OBX|237|CE|NuSGA01800^SGA rating^ADM||1^A= Well nourished||||||F
OBX|238|CE|NuSGA01801^SGA Rating^ADM||1^A= Well nourished||||||F
OBX|239|CE|NuSGACFN00^Factors contributing to nutritional status^ADM||1^Cachexia||||||F
OBX|240|CE|NuSGACNI00^Current nutrient intake^ADM||2^Inadequate||||||F
OBX|241|CE|NuSGAFCA00^Current functional capacity^ADM||2^Reduced capacity||||||F
OBX|242|TX|NuSGAFCD00^Reduced functional capacity duration^ADM||3 months||||||F
OBX|243|CE|NuSGAFCP00^Functional capacity in past 2 weeks^ADM||3^Decreased||||||F
OBX|244|CE|NuSGAFCT00^Reduced functional capacity type^ADM||1^Difficulty ambulating/ADL||||||F
OBX|245|TX|NuSGAHMR00^High metabolic requirement^ADM||N||||||F
OBX|246|CE|NuSGAIIT00^Inadequate intake type^ADM||2^Full liquid diet||||||F
OBX|247|CE|NuSGAIP200^Nutrient intake in past 2 weeks^ADM||3^Inadequate (not improved)||||||F
OBX|248|CE|NuSGALBF00^Loss of body fat^ADM||2^Mild/Moderate||||||F
OBX|249|CE|NuSGALMM00^Loss of muscle mass^ADM||3^Severe||||||F
OBX|250|CE|NuSGANFW00^Non fluid weight loss in past 6 months^ADM||2^5-10%/ongoing||||||F
OBX|251|CE|NuSGAPEA00^Presence of edema/ascites^ADM||2^Mild/Moderate||||||F
OBX|252|CE|NuSGASAI00^Current symptoms affecting intake^ADM||3^Anorexia~4^Nausea~8^Feels full quickly||||||F
OBX|253|CE|NuSGASFQ00^Current symptoms frequency^ADM||1^Intermittent/Mild/Few||||||F
OBX|254|CE|NuSGASPT00^Symptoms in the past two weeks^ADM||2^Improving||||||F
OBX|255|TX|NuSGAWCT00^Weight change amount in past 2 weeks^ADM||3.0||||||F
OBX|256|TX|NuTEEDCO00^Nutrition education content (specify)^ADM||NG feeds||||||F
OBX|257|TX|NuWT000000^Weight used for energy calculation^ADM||75.000||||||F
OBX|258|TX|NuWT000100^Weight used for protein calculation^ADM||75.000||||||F
OBX|259|CE|NuWTCH0000^Weight change calculation based on^ADM||1^Usual/Previous weight||||||F
OBX|260|TX|OEDIAG^Diagnosis:^ADM||dx dec 13||||||F
OBX|261|CE|OEISO^Infection Control:^ADM||A^Airborne||||||F
OBX|262|CE|OhIN000300^Information source^ADM||1^Patient~2^Health record review~15^Significant other||||||F
OBX|263|TX|OhOTSMRT00^OT SMART goals^ADM||OT smart goals from UAP OT~line 2~line 3 UAP OT||||||F
OBX|264|TX|OhOTSTUP00^OT patient status update^ADM||patient status update from UAP OT line 1~patient status update from UAP OT line 2~patient status update from UAP OT line 3||||||F
OBX|265|TX|OhPLNDET00^Plan details^ADM||Plan details from UAP OT~line 2~line 3||||||F
OBX|266|TX|OhPT000101^Treatment analysis^ADM||analysis from UAP PT||||||F
OBX|267|TX|OhPT000201^Patient's concerns^ADM||patients subjective report from UAP PT||||||F
OBX|268|TX|OhPTSTUP00^Patient status update^ADM||Patient status update from UAP PT~line 2 UAP PT~line 3 UAP PT||||||F
OBX|269|TX|OtLABMED01^Medications and labs^ADM||respiratory acidosis||||||F
OBX|270|TX|OtPDABTR00^Appointments, booking and transportation ? ? ^ADM||New appt||||||F
OBX|271|TX|OtPDCAR00^Consults and referrals^ADM||line 1~line 2~line 3~dec 13||||||F
OBX|272|TX|OtPDGLUC00^Glucometer frequency^ADM||Gluc Q6H||||||F
OBX|273|TX|OtPDPCCN00^PCC notes^ADM||Testing PCC Notes~Line 2~Line 3~Line 4||||||F
OBX|274|TX|OtPDSPDO00^Surgery/Procedure 1 date^ADM||20191204||||||F
OBX|275|TX|OtPDSPDT00^Surgery/Procedure 2 date^ADM||20191121||||||F
OBX|276|TX|OtPDSPON00^Surgery/Procedure 1^ADM||trach||||||F
OBX|277|TX|OtPDSPTW00^Surgery/Procedure 2^ADM||hernia||||||F
OBX|278|TX|OtPDSSUM00^Shift summary^ADM||New documentation in Shift summary Dec 13||||||F
OBX|279|TX|OtPDVSIG00^Vital signs frequency^ADM||VS Q4H||||||F
OBX|280|TX|OtPDWEIG00^Weight frequency^ADM||Weight OD||||||F
OBX|281|TX|OtRPOSBD00^Recommendations for positioning in bed^ADM||bed possitioning recommendations||||||F
OBX|282|TX|OtRSEATG00^Recommendations for seating^ADM||recommendations for seating||||||F
OBX|283|CE|OtRSITTL00^Recommendation for sitting tolerance^ADM||2^1 hour||||||F
OBX|284|TX|OtSGBMGM00^Recommendations for behavioural management^ADM||recommendations for behaviour management||||||F
OBX|285|TX|PdDGFQ0000^Dressing change frequency^ADM||Dressing change BID||||||F
OBX|286|TX|PdOIOUTP01^Intake/Output^ADM||||||||F
OBX|287|TX|PdOOTCOM01^OT comments^ADM||OT comments from PDS||||||F
OBX|288|TX|PdPCCCN000^PCC/CN notes^ADM||Testing PCC/CN notes on PCStest, Report 1~Dec 4,  2019~DM||||||F
OBX|289|TX|PdPTCOMM01^PT comments^ADM||PT comments from PDS||||||F
OBX|290|TX|PdTUBDRN00^Tubes/Drains/Lines^ADM||testing tubes lines and drains||||||F
OBX|291|TX|ReAENTRY00^Air entry adequate throughout^ADM||Y||||||F
OBX|292|CE|ReARBLPS01^Arterial blood gas puncture site^ADM||1^Right radial||||||F
OBX|293|TX|ReARTIND01^Arterial catheter insertion date^ADM||20200114||||||F
OBX|294|TX|ReARTINT01^Arterial catheter insertion time^ADM||0430||||||F
OBX|295|CE|ReAULOCT00^Auscultation location^ADM||7^Left lung||||||F
OBX|296|TX|ReAWISDT00^Date inline suction catheter initiated or changed^ADM||20200114||||||F
OBX|297|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||Y||||||F
OBX|298|TX|ReBGATSU00^ABG attempt successful^ADM||Y||||||F
OBX|299|CE|ReBR000800^Two patient identifiers checked^ADM||1^Patient name band~3^MAR||||||F
OBX|300|CE|ReCOLMET01^Secretions collection method^ADM||2^Open catheter||||||F
OBX|301|TX|ReCPAPBI00^On home CPAP/BIPAP therapy^ADM||Y||||||F
OBX|302|TX|ReDIFFAW01^Difficult airway^ADM||N||||||F
OBX|303|CE|ReENTRTU00^ETT tube location^ADM||1^Oral||||||F
OBX|304|CE|ReENTUSI02^Endotracheal tube size^ADM||5^8.0 mm||||||F
OBX|305|CE|ReETINME00^Intubation method^ADM||1^Direct laryngoscopy||||||F
OBX|306|TX|ReETINNA01^Number of intubation attempts^ADM||2||||||F
OBX|307|CE|ReETINPR02^Reason for intubation^ADM||1^Ventilatory failure||||||F
OBX|308|TX|ReETINPX01^Intubation location confirmation via X-ray^ADM||N||||||F
OBX|309|TX|ReETINSD01^Intubation securement device used^ADM||AnchorFast||||||F
OBX|310|TX|ReETTBBI00^Bite block inserted^ADM||N||||||F
OBX|311|CE|ReETTBTY03^Endotracheal tube type^ADM||1^Evac||||||F
OBX|312|TX|ReETTCUP01^Endotracheal tube cuff pressure^ADM||24||||||F
OBX|313|TX|ReHOOXPR00^Home oxygen provider^ADM||Vitalaire||||||F
OBX|314|TX|ReIN000102^ETT confirmed position^ADM||24.0||||||F
OBX|315|TX|ReINLINE02^Inline suction catheter change due date^ADM||21 Jan 2020||||||F
OBX|316|TX|ReINPOTN01^Initial position at teeth/nares^ADM||23.0||||||F
OBX|317|TX|ReINSDAT00^Endotracheal tube insertion date^ADM||20200114||||||F
OBX|318|TX|ReINSTIM00^Endotracheal tube insertion time^ADM||0400||||||F
OBX|319|CE|ReINTUBA01^Intubated by^ADM||1^Physician||||||F
OBX|320|TX|ReMEDCON01^Controller inhalers used at home^ADM||Spiriva||||||F
OBX|321|TX|ReMEDHOM02^Rescue inhalers used at home^ADM||Salbutamol, atrovent||||||F
OBX|322|TX|ReNOINDA01^Non-invasive ventilation initiation date^ADM||20200114||||||F
OBX|323|TX|ReNOIVTI01^Non-invasive ventilation initiation time^ADM||0300||||||F
OBX|324|CE|ReOAINRE01^Oral airway insertion reason^ADM||1^Obtunded||||||F
OBX|325|TX|ReOARMDT00^Oral airway removal date^ADM||20200114||||||F
OBX|326|TX|ReOARMTM00^Oral airway removal time^ADM||0300||||||F
OBX|327|CE|ReOASIZE01^Oral airway size^ADM||6^80 mm||||||F
OBX|328|TX|ReOXHOFL02^Home oxygen flow rate^ADM||2||||||F
OBX|329|CE|ReOXHOUS00^Home oxygen use^ADM||1^24 hour||||||F
OBX|330|CE|ReOXYTHE04^Oxygen therapy delivery method^ADM||3^Heated high flow cannula||||||F
OBX|331|CE|RePHASE000^Phase^ADM||1^Inspiration~2^Expiration||||||F
OBX|332|TX|RePREDIF00^Previous difficult airway designation^ADM||N||||||F
OBX|333|CE|ReRECHEX01^Chest expansion^ADM||1^Symmetrical||||||F
OBX|334|CE|ReREDISI00^Respiratory distress indicators^ADM||1^Accessory muscle use||||||F
OBX|335|CE|ReREDPTH00^Respiratory depth^ADM||2^Shallow||||||F
OBX|336|CE|ReRERTCO01^RT consult type^ADM||1^Initial referral||||||F
OBX|337|CE|ReRPNM0000^Respiratory pattern^ADM||2^Tachypneic||||||F
OBX|338|CE|ReSCAMNT00^Secretions amount^ADM||2^Small||||||F
OBX|339|CE|ReSCCOLR00^Secretions colour^ADM||2^White||||||F
OBX|340|CE|ReSCDESC02^Secretions description^ADM||1^Mucoid||||||F
OBX|341|CE|ReSCSRCE00^Secretions source^ADM||1^Endotracheal||||||F
OBX|342|CE|ReSE000100^Secretion source^ADM||1^Endotracheal||||||F
OBX|343|TX|ReSECCOM00^Secretions comments^ADM||comments||||||F
OBX|344|TX|ReSECMET00^Secretions collection method other^ADM||secretion collection method other||||||F
OBX|345|TX|ReTORERA00^Respiratory rate (total)^ADM||26||||||F
OBX|346|TX|ReTRASDA00^Assess need for tracheostomy date^ADM||28 Jan 2020||||||F
OBX|347|CE|ReVE000302^Ventilator mode^ADM||5^PCVG||||||F
OBX|348|TX|ReVE000602^Ventilator change due date^ADM||13 Feb 2020||||||F
OBX|349|TX|ReVE000902^Respiratory rate (set)^ADM||18||||||F
OBX|350|TX|ReVE001000^Adult ventilation total respiratory rate^ADM||18||||||F
OBX|351|TX|ReVE001101^Adult ventilation set tidal volume^ADM||500||||||F
OBX|352|TX|ReVE001201^Adult ventilation effective tidal volume^ADM||480||||||F
OBX|353|TX|ReVE002200^Adult ventilation peak airway pressure^ADM||36||||||F
OBX|354|TX|ReVE003700^Adult ventilation evac patency and vacuum pressure checked^ADM||Y||||||F
OBX|355|TX|ReVE005102^Safety equipment present and checked^ADM||Y||||||F
OBX|356|TX|ReVE005200^Adult ventilation end tidal carbon dioxide (CO2)^ADM||43.0||||||F
OBX|357|CE|ReVE007601^Rationale for non-invasive ventilation^ADM||1^COPD exacerbation||||||F
OBX|358|CE|ReVE007901^Mask type^ADM||1^Mouth and nose||||||F
OBX|359|CE|ReVE008002^Mask size^ADM||2^Medium||||||F
OBX|360|TX|ReVE008102^IPAP^ADM||12||||||F
OBX|361|TX|ReVE008202^EPAP^ADM||8||||||F
OBX|362|CE|ReVE009103^Ventilation medications salbutamol administration^ADM||2^100 mcg puff x 2||||||F
OBX|363|TX|ReVE012101^FiO2 (set)^ADM||0.40||||||F
OBX|364|TX|ReVE012400^Adult non-invasive vent fraction of inspired O2 (measured)^ADM||0.4||||||F
OBX|365|CE|ReVE012801^Non-invasive ventilation mode^ADM||1^BiPAP (ST)||||||F
OBX|366|TX|ReVENINI00^Date ventilation initiated^ADM||20200114||||||F
OBX|367|CE|ReWRKBRE00^Work of breathing^ADM||1^Normal||||||F
OBX|368|TX|SpCARPOS00^Recommendations for car seat/positioning^ADM||recommendations for care/seat positioning||||||F
OBX|369|CE|SpCONFOR00^Consent for intervention^ADM||1^Verbal||||||F
OBX|370|CE|SpCONPAT00^Consent received from patient^ADM||1^Verbal||||||F
OBX|371|CE|SpCONRIS00^Assessment/Treatment benefits and risks explained to^ADM||1^Patient||||||F
OBX|372|CE|SpCONTYP00^Consent received for^ADM||1^Assessment~2^Treatment plan||||||F
OBX|373|TX|SpOSPATT01^Observed sleep pattern^ADM||observed sleep patter||||||F
OBX|374|TX|SpPRLOTH00^Physical restraint location other^ADM||restraint location other||||||F
OBX|375|CE|SpPRSCHE00^Physical restraint safety checks^ADM||4^Body in alignment||||||F
OBX|376|TX|SpPRSCOT00^Physical restraint safety checks other^ADM||restraint safety checks other||||||F
OBX|377|TX|SpREPSLE00^Reported sleep pattern^ADM||reported sleep pattern||||||F
OBX|378|TX|SpREST0001^Family informed of need for restraint measures^ADM||Y||||||F
OBX|379|CE|SpRESTRA00^Physical restraint location^ADM||2^Left wrist||||||F
OBX|380|TX|SpSLEAID00^Sleep aid PRN given^ADM||Y||||||F
OBX|381|TX|TeEDINTR00^Interpreter utilized^ADM||N||||||F
OBX|382|TX|TeEDNAME00^Name of person if other than patient^ADM||Nicole||||||F
OBX|383|CE|TeEDOUTM00^Learning outcome^ADM||1^Shows understanding||||||F
OBX|384|CE|TeEDPRVD00^Education provided to^ADM||1^Patient~3^Family||||||F
OBX|385|TX|VsBPDIAO01^Blood pressure diastolic^ADM||85||||||F
OBX|386|CE|VsBPPOST02^Patient position^ADM||2^Supine||||||F
OBX|387|TX|VsBPSYSO01^Blood pressure systolic^ADM||145||||||F
OBX|388|CE|VsGENDER00^Gender^ADM||1^Male||||||F
OBX|389|TX|VsHRADLT01^Heart rate^ADM||120||||||F
OBX|390|CE|VsHRMETH00^Heart rate method used^ADM||4^Monitor||||||F
OBX|391|TX|VsHTCM0100^Current height^ADM||170.0||||||F
OBX|392|TX|VsOXDRAD01^Oxygen therapy delivery rate^ADM||5||||||F
OBX|393|TX|VsPOOSAD00^Pulse oximetry oxygen saturation^ADM||92||||||F
OBX|394|TX|VsRESPAD00^Respiration rate^ADM||26||||||F
OBX|395|TX|VsSOXYGE00^Oxygen saturation (O2) goal^ADM||Sat>92%||||||F
OBX|396|CE|VsWGCBMI01^Weight used to calculate body mass index^ADM||1^Current weight||||||F
OBX|397|TX|VsWT000101^Current Weight^ADM||75.000||||||F
OBX|398|CE|VsWT000400^Current weight source^ADM||1^Measured||||||F
OBX|399|TX|VsWT002701^Usual/Previous weight^ADM||76.000||||||F
OBX|400|TX|VsWT004100^Predicted weight^ADM||65.87||||||F
OBX|401|CE|VsWT004900^Height or length source^ADM||1^Measured (head-to-toe)||||||F
OBX|402|TX|VsWT005300^Body mass index^ADM||25.9||||||F
OBX|403|TX|VsWTGRAM00^Weight (Calculated Grams)^ADM||75000.000||||||F
AL1|1|DA|F006001545^morphine|MI|Hives/Urticaria       *AL|20191021
ZFD|ZTEST^Test Provider^IM/IT^Use Only^^^^500001^DOC||||ZTEST^Test Provider^IM/IT^Use Only^^^^500001^DOC|ZTEST^Test Provider^IM/IT^Use Only^^^^500001^DOC|
ZFH|LUMED||||||

MSH|^~\&|ADM|SMH|||202001141311||ADT^A04|4146087|D|2.2|||AL|NE
EVN|A04|202001141311||||202001131310
PID|1|FHATVIG0013014|SM00047233|SM47012|SMITHSON^LUMED||19711110|F|||1845 KENNEDY RD^^SURREY^BC^V1M 2R2|||||||SM003947/19|9874757361
PV1|1|O|SM.CNCL/O||||ZTEST^Test Provider^IM/IT^Use Only^^^^^^^^^XX|||||||||||REF|||||||||||||||||||||SMH|||||202001131310|
PV2|||SWITCHED SM3928/19 TO SM47239
OBX|1|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20181209||||||F
AL1|1|DA|F001900590^No Known Drug Allergies|||20200114
ZFD|ZTEST^Test Provider^IM/IT^Use Only^^^^500001^DOC||||ZTEST^Test Provider^IM/IT^Use Only^^^^500001^DOC|
ZFH|LUMED||||||

